COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry - UAE

Partner, Melissa Murray and Senior Associate, Surabhi Singhi provided content for the United Arab Emirates.

COVID-19 presents an unprecedented challenge to the global life sciences industry. Members of Bird & Bird's International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships with regulatory bodies, have worked together to provide an update in the form of a Q&A for each of the countries we are located. This update aims to provide guidance on the responses of EU, Asia-Pac and UAE regulators in the areas of clinical trials, medical devices, market access, public procurement and compulsory licensing.

Read more >

 

Latest insights

More Insights
Car on a road between forest and water

Navigating the shift to electric vehicles and sustainable practices in the automotive industry

Dec 06 2023

Read More
multicoloured curiosity line on blue background

ICO Enforcement Updates (PECR) - December 2023

Dec 06 2023

Read More
Cyclists and pedestrians on curved road

The continuing rise of Consumer Litigation in the EU: a deep dive into current trends - Trend 1 - Consumer Class Actions

Dec 06 2023

Read More

Related capabilities